H.R. 9635 (119th)Congressional Activities
To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations
domestic policy
Current stageCommittee
Referred to the House Committee on Energy and Commerce.
Introduced
Committee
Floor
President
Law
Congressional Activities
This tab collects committee work, CRS research, hearings, and amendment activity as those sources become available for the bill.
No congressional activity records are linked to this bill yet.